Yunkang Group Limited (2325.HK)

HKD 3.2

(0.0%)

EBITDA Summary of Yunkang Group Limited

  • Yunkang Group Limited's latest annual EBITDA in 2023 was 25.06 Million CNY , down -108.72% from previous year.
  • Yunkang Group Limited's latest quarterly EBITDA in 2024 Q2 was -48.1 Million HKD , up 0.15% from previous quarter.
  • Yunkang Group Limited reported an annual EBITDA of 619.32 Million CNY in 2022, up 10.0% from previous year.
  • Yunkang Group Limited reported an annual EBITDA of 524.28 Million CNY in 2021, up 48.11% from previous year.
  • Yunkang Group Limited reported a quarterly EBITDA of -48.1 Million HKD for 2024 Q2, up 0.15% from previous quarter.
  • Yunkang Group Limited reported a quarterly EBITDA of 21.07 Million HKD for 2023 Q2, down -5.52% from previous quarter.

Annual EBITDA Chart of Yunkang Group Limited (2023 - 2018)

Historical Annual EBITDA of Yunkang Group Limited (2023 - 2018)

Year EBITDA EBITDA Growth
2023 25.06 Million CNY -108.72%
2022 619.32 Million CNY 10.0%
2021 524.28 Million CNY 48.11%
2020 382.01 Million CNY 1678.09%
2019 35.32 Million HKD 187.13%
2018 1.68 Million HKD 0.0%

Peer EBITDA Comparison of Yunkang Group Limited

Name EBITDA EBITDA Difference
Life Healthcare Group Limited 27.68 Million HKD 9.459%
China Biotech Services Holdings Limited -73.45 Million HKD 134.128%